Electromyoneurography and laboratory findings in a case of Guillain-Barré syndrome after second dose of Pfizer COVID-19 vaccine.
- Published in:
- Human Vaccines & Immunotherapeutics, 2021, v. 17, n. 11, p. 4093, doi. 10.1080/21645515.2021.1954826
- By:
- Publication type:
- Article